• 1. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 2. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Methyl (3S)-3-amino-3-phenylpropanoate (CAS No. 37088-66-7): A Comprehensive Overview

Methyl (3S)-3-amino-3-phenylpropanoate, identified by its Chemical Abstracts Service Number (CAS No.) 37088-66-7, is a compound of significant interest in the field of pharmaceutical chemistry and biochemistry. This molecule, characterized by its specific stereochemistry and structural features, has garnered attention due to its potential applications in drug development and biochemical research. The stereochemical configuration at the chiral center, specifically the (3S) configuration, plays a crucial role in determining its biological activity and interaction with biological targets.

The structure of Methyl (3S)-3-amino-3-phenylpropanoate consists of a phenyl group attached to a propanoate backbone with an amine substituent at the third carbon atom. This unique arrangement contributes to its distinct chemical properties and reactivity. The presence of the stereocenter at the third carbon makes this compound an enantiomer, with the (3S) form being particularly studied for its pharmacological properties. The compound's solubility, stability, and metabolic pathways are also influenced by this stereochemical feature, making it a subject of extensive research in medicinal chemistry.

In recent years, there has been growing interest in the development of chiral drugs due to their enhanced specificity and reduced side effects compared to their racemic counterparts. Methyl (3S)-3-amino-3-phenylpropanoate exemplifies this trend, as its enantiomeric purity is critical for achieving desired therapeutic outcomes. Researchers have been exploring synthetic routes to produce this compound with high enantiomeric excess, ensuring that the pharmacological effects are maximized while minimizing potential adverse reactions.

One of the most compelling aspects of Methyl (3S)-3-amino-3-phenylpropanoate is its potential role as a building block in the synthesis of more complex pharmaceutical agents. Its structural motifs are reminiscent of natural products and bioactive molecules, making it a valuable intermediate in drug discovery programs. For instance, derivatives of this compound have been investigated for their antimicrobial and anti-inflammatory properties. The phenyl group and the amine moiety provide multiple sites for functionalization, allowing chemists to tailor the molecule's properties for specific therapeutic applications.

Advances in computational chemistry and molecular modeling have further enhanced our understanding of Methyl (3S)-3-amino-3-phenylpropanoate's interactions with biological targets. These studies have revealed insights into how the compound binds to enzymes and receptors, providing a foundation for rational drug design. By leveraging these insights, researchers can optimize the molecule's pharmacokinetic and pharmacodynamic profiles, ultimately leading to more effective treatments for various diseases.

The synthesis of Methyl (3S)-3-amino-3-phenylpropanoate has been refined through multiple methodologies, each offering distinct advantages in terms of yield, purity, and scalability. One common approach involves asymmetric synthesis techniques that exploit chiral catalysts or auxiliaries to achieve high enantiomeric excess. These methods are particularly valuable in industrial settings where large-scale production is required. Additionally, biocatalytic approaches using enzymes have emerged as a sustainable alternative to traditional synthetic routes, offering improved selectivity and reduced environmental impact.

Recent studies have also highlighted the importance of understanding the metabolic fate of Methyl (3S)-3-amino-3-phenylpropanoate in vivo. Metabolomics techniques have been employed to identify key metabolites and pathways involved in drug metabolism. This information is crucial for predicting potential drug-drug interactions and optimizing dosing regimens. Furthermore, kinetic studies have provided insights into how the compound is processed by different organs, helping to predict its overall bioavailability and efficacy.

The pharmaceutical industry continues to invest heavily in research related to Methyl (3S)-3-amino-3-phenylpropanoate due to its promising therapeutic potential. Collaborative efforts between academic institutions and pharmaceutical companies have led to several innovative approaches for its application in drug development. These collaborations leverage expertise from various disciplines, including organic chemistry, medicinal chemistry, pharmacology, and bioinformatics, to accelerate the discovery and development of new treatments.

Looking ahead, the future prospects for Methyl (3S)-3-amino-3-phenylpropanoate are bright, with ongoing research aimed at expanding its applications in medicine and biotechnology. Novel synthetic strategies are being explored to improve production efficiency and cost-effectiveness, while computational methods are being refined to enhance our understanding of its biological interactions. As our knowledge base grows, it is likely that this compound will play an increasingly important role in addressing unmet medical needs.

• 6335-76-8(Ethyl 3-amino-3-phenylpropanoate)
• 14898-52-3(methyl 3-amino-3-phenylpropanoate)
• 3082-68-6((βR)-β-Aminobenzenepropanoic Acid Ethyl Ester)
• 3082-69-7((βS)-β-Aminobenzenepropanoic Acid Ethyl Ester)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)